News|Articles|June 1, 2007

FDA pipeline preview, June 2007

The latest FDA action (through June 2007) related to sipuleucel-T (Provenge), tramadol (CIP-Tramadol ER), isotretinoin (CIP-Isotretinoin), bazedoxifene (Viviant), irbesartan plus hydrochlorothiazide (Avalide), prednisolone 1.0% plus tobramycin 0.3% ophthalmic suspension (T-Pred), pixantrone, SPRC-AB01

Approvable designations

Recommendation for approval

Nonapprovable designation

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.


Latest CME